Published in Br J Psychiatry on August 01, 1998
The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry (2003) 3.04
Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease. Am J Psychiatry (2010) 1.95
Genomic copy number variation in disorders of cognitive development. J Am Acad Child Adolesc Psychiatry (2010) 1.47
Chromosomal abnormalities and schizophrenia. Am J Med Genet (2000) 1.36
Patterns of dysmorphic features in schizophrenia. Am J Med Genet (2001) 1.03
A 4q35.2 subtelomeric deletion identified in a screen of patients with co-morbid psychiatric illness and mental retardation. BMC Med Genet (2004) 0.92
Elevated rates of schizophrenia in a familial sample with mental illness and intellectual disability. J Intellect Disabil Res (2004) 0.87
Sequence analysis of P21-activated kinase 3 (PAK3) in chronic schizophrenia with cognitive impairment. Schizophr Res (2008) 0.79
The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability. Nat Genet (2017) 0.76
Mental health services for people with learning disabilities. People with comorbidity can fall between two stools. BMJ (2001) 0.75
Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet (2000) 7.16
Whole-genome association study of bipolar disorder. Mol Psychiatry (2008) 6.80
Schizophrenia and affective disorders--cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet (2001) 4.77
Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry (2008) 3.85
Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ (1994) 3.33
Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet (1976) 3.14
Magnetic resonance imaging of brain in people at high risk of developing schizophrenia. Lancet (1999) 2.47
Structural disconnectivity in schizophrenia: a diffusion tensor magnetic resonance imaging study. Br J Psychiatry (2003) 2.31
Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci U S A (1994) 2.12
Presenilin-I, presenilin-II, and VLDL-R associations in early onset Alzheimer's disease. Lancet (1997) 2.06
Complications of pregnancy and delivery in relation to psychosis in adult life: data from the British perinatal mortality survey sample. BMJ (1991) 2.03
Service provision for people with schizophrenia. II. Role of the general practitioner. Br J Psychiatry (1997) 1.88
Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users. Br J Psychiatry (1999) 1.86
Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. Mol Psychiatry (2001) 1.81
The Northwick Park electroconvulsive therapy trial. Lancet (1981) 1.79
The dementia of dementia praecox. Acta Psychiatr Scand (1978) 1.79
Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch Gen Psychiatry (1986) 1.74
Schizophrenic patients discharged from hospital--a follow-up study. Br J Psychiatry (1984) 1.71
Dangerous behaviour preceding first admissions for schizophrenia. Br J Psychiatry (1992) 1.71
The effects of a neuregulin 1 variant on white matter density and integrity. Mol Psychiatry (2007) 1.68
Acetylator status and response to phenelzine in depressed patients. Lancet (1973) 1.67
A locus for bipolar affective disorder on chromosome 4p. Nat Genet (1996) 1.67
Neurotic illness and its response to anxiolytic and antidepressant treatment. Psychol Med (1980) 1.66
Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia. Biol Psychiatry (2001) 1.59
New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet (1997) 1.55
A MRI study of ocular hypertelorism in individuals at high risk of developing schizophrenia. Schizophr Res (2001) 1.54
Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study. Psychol Med (2000) 1.52
Concordance by sex in sibling pairs with schizophrenia is paternally inherited. Evidence for a pseudoautosomal locus. Br J Psychiatry (1989) 1.50
Unsuspected organic disease in chronic schizophrenia demonstrated by computed tomography. J Neurol Neurosurg Psychiatry (1980) 1.48
Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet (1978) 1.47
The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial. Ann Oncol (2012) 1.46
Disruption of the neuronal PAS3 gene in a family affected with schizophrenia. J Med Genet (2003) 1.46
Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics. Arch Gen Psychiatry (1982) 1.44
Small intestine permeability in schizophrenia. Br J Psychiatry (1989) 1.41
Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Mol Psychiatry (2005) 1.41
Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry (1989) 1.38
The Northwick Park Study of first episodes of schizophrenia. I. Presentation of the illness and problems relating to admission. Br J Psychiatry (1986) 1.36
Neuropsychological assessment of young people at high genetic risk for developing schizophrenia compared with controls: preliminary findings of the Edinburgh High Risk Study (EHRS). Psychol Med (1999) 1.34
Deficits in facial, body movement and vocal emotional processing in autism spectrum disorders. Psychol Med (2010) 1.33
Comparative trial of L-tryptophan and amitriptyline in depressive illness. Psychol Med (1976) 1.32
Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorder. Psychiatr Genet (2001) 1.30
A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry (1986) 1.27
Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees. Arch Gen Psychiatry (1991) 1.27
Interacting haplotypes at the NPAS3 locus alter risk of schizophrenia and bipolar disorder. Mol Psychiatry (2008) 1.27
Association of Neuregulin 1 with schizophrenia and bipolar disorder in a second cohort from the Scottish population. Mol Psychiatry (2006) 1.23
Volumetric magnetic resonance imaging study of the brain in subjects with sex chromosome aneuploidies. J Neurol Neurosurg Psychiatry (1999) 1.20
fMRI correlates of state and trait effects in subjects at genetically enhanced risk of schizophrenia. Brain (2004) 1.20
Presence of multiple functional polyadenylation signals and a single nucleotide polymorphism in the 3' untranslated region of the human serotonin transporter gene. J Neurochem (1999) 1.18
The relationship between acetylator status and inhibition of monoamine oxidase, excretion of free drug and antidepressant response in depressed patients on phenelzine. Psychopharmacologia (1976) 1.15
Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment. Br Med J (1975) 1.13
Disruption of a brain transcription factor, NPAS3, is associated with schizophrenia and learning disability. Am J Med Genet B Neuropsychiatr Genet (2005) 1.13
Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls. Psychiatry Res (2001) 1.12
Cytogenetic and genetic evidence supports a role for the kainate-type glutamate receptor gene, GRIK4, in schizophrenia and bipolar disorder. Mol Psychiatry (2006) 1.12
Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia. Soc Psychiatry Psychiatr Epidemiol (2001) 1.12
Comparative trial of L-tryptophan and E.C.T. in severe depressive illness. Lancet (1974) 1.11
Mutational screening and association study of glutamate decarboxylase 1 as a candidate susceptibility gene for bipolar affective disorder and schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2005) 1.11
Edinburgh high risk study--findings after four years: demographic, attainment and psychopathological issues. Schizophr Res (2000) 1.10
Neuroanatomy of comorbid schizophrenia and learning disability: a controlled study. Lancet (1999) 1.10
Association of the mu-opioid receptor gene with smoking cessation. Pharmacogenomics J (2007) 1.09
Prevalence of psychiatric morbidity among remand prisoners in Scotland. Br J Psychiatry (1995) 1.09
A genome scan and follow-up study identify a bipolar disorder susceptibility locus on chromosome 1q42. Mol Psychiatry (2004) 1.08
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch. Pharmacogenomics J (2007) 1.08
The Northwick Park "functional" psychosis study: diagnosis and treatment response. Lancet (1988) 1.07
A diffusion tensor MRI study of white matter integrity in subjects at high genetic risk of schizophrenia. Schizophr Res (2008) 1.06
Clinical correlates of postmortem brain changes in schizophrenia: decreased brain weight and length correlate with indices of early impairment. J Neurol Neurosurg Psychiatry (1994) 1.06
Characteristics of patients with schizophrenia or neurological disorder and virus-like agent in cerebrospinal fluid. Lancet (1979) 1.06
Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia. Br J Psychiatry (2001) 1.05
Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder. Mol Psychiatry (2006) 1.05
Auditory P300 event-related potentials and neuropsychological performance in schizophrenia and bipolar affective disorder. Biol Psychiatry (1995) 1.05
Criminality and antisocial behaviour in unselected men with sex chromosome abnormalities. Psychol Med (1999) 1.04
Altered cerebral perfusion measured by SPECT in relatives of patients with schizophrenia. Correlations with memory and P300. Br J Psychiatry (1999) 1.03
Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorder. Psychiatr Genet (1996) 1.02
Set shifting and reversal learning in patients with bipolar disorder or schizophrenia. Psychol Med (2008) 1.01
Nuts and bolts of psychiatric genetics: building on the Human Genome Project. Trends Genet (2001) 1.01
Life events in suicide and undetermined death in south-east Scotland: a case-control study using the method of psychological autopsy. Soc Psychiatry Psychiatr Epidemiol (1999) 1.00
Segregation analysis of complex phenotypes: an application to schizophrenia and auditory P300 latency. Psychiatr Genet (1994) 1.00
Lateral ventricular size in schizophrenia: relationship to the disease process and its clinical manifestations. Psychol Med (1985) 0.99
The occurrence of organic disease of possible or probable aetiological significance in a population of 268 cases of first episode schizophrenia. Psychol Med (1987) 0.99
The disabilities of chronic schizophrenia--their nature and the factors contributing to their development. Br J Psychiatry (1980) 0.99
Theory of mind and psychoses. Psychol Med (1998) 0.99
Methodological issues in volumetric magnetic resonance imaging of the brain in the Edinburgh High Risk Project. Psychiatry Res (1999) 0.98
Group psychological treatment for chest pain with normal coronary arteries. QJM (1999) 0.97
The spectrum of structural brain changes in schizophrenia: age of onset as a predictor of cognitive and clinical impairments and their cerebral correlates. Psychol Med (1989) 0.97
Childhood behaviour, psychotic symptoms and psychosis onset in young people at high risk of schizophrenia: early findings from the edinburgh high risk study. Psychol Med (2002) 0.96
The relationship of anterior thalamic radiation integrity to psychosis risk associated neuregulin-1 variants. Mol Psychiatry (2009) 0.96
Transcriptional regulation of neurodevelopmental and metabolic pathways by NPAS3. Mol Psychiatry (2011) 0.96
Detecting QTLs for uni- and bipolar disorder using a variance component method. Psychiatr Genet (1999) 0.96